Navigate this market better. Subscribe for FREE stock alerts and information.

Thursday, July 17, 2014

Baxter earnings, sales beat estimates, (NYSE: BAX), (NYSE: TRI), (TSE: TRI.TO)

Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly earnings and revenue, helped by surging sales in its medical products division. Net adjusted income rose to $692 million, or $1.26 per share in the second quarter ended June 30, from $639 million, or $1.16 per share, a year earlier.Revenue rose about 16 percent to $4.3 billion.Analysts on average had expected adjusted earnings of $1.22 per share, excluding items, on revenue of $4.12 billion, according to Thomson Reuters I/B/E/S.Deerfield, Illinois-based Baxter's stock closed at $76.60 on the New York Stock Exchange on Wednesday.

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Shares of BAX fell by 0.21% or $-0.16/share to $76.60. In the past year, the shares have traded as low as $62.80 and as high as $77.14. On average, 2551740 shares of BAX exchange hands on a given day and today's volume is recorded at 2041037.

Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.71% or $0.26/share to $37.03. In the past year, the shares have traded as low as $32.87 and as high as $38.73. On average, 758952 shares of TRI exchange hands on a given day and today's volume is recorded at 397629.

Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.63% or $0.25/share to $39.77. In the past year, the shares have traded as low as $34.52 and as high as $42.10. On average, 589286 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 261009.



Source